Product Type
Condition
Binding
Collectible Attributes
Free Shipping
Seller Location
Seller Rating
Published by Psychology Press, 1997
ISBN 10: 0805824030ISBN 13: 9780805824032
Seller: Book House in Dinkytown, IOBA, Minneapolis, MN, U.S.A.
Association Member: IOBA
Book
Paperback. Condition: Very Good. Lawrence Erlebaum Associates, 1997; First Paperback Printing with full number line; xxiii, 470p. Spine is uncreased, binding tight and sturdy; text, illustrations also very good; toning to spine, text remains clearly legible; minor wear to edges of wraps. Due to the size/weight of this book extra charges may apply for international shipping. Ships from Dinkytown in Minneapolis, Minnesota.
Published by Lawrence Erlbaum Assoc Inc, 1997
ISBN 10: 0805824030ISBN 13: 9780805824032
Seller: Revaluation Books, Exeter, United Kingdom
Book
Paperback. Condition: Brand New. 1st edition. 496 pages. 9.00x6.00x1.25 inches. In Stock.
Published by Psychology Press, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: Ammareal, Morangis, France
Book
Hardcover. Condition: Très bon. Ancien livre de bibliothèque. Couverture légèrement déchirée. Salissures sur la tranche. Edition 1997. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Slightly torn cover. Stains on the edge. Edition 1997. Ammareal gives back up to 15% of this item's net price to charity organizations.
Published by Psychology Press 1997-10-13, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: Chiron Media, Wallingford, United Kingdom
Book
Hardcover. Condition: New.
Published by Springer, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Soft Cover. Condition: new.
Published by Springer, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: booksXpress, Bayonne, NJ, U.S.A.
Book
Hardcover. Condition: new.
Published by Psychology Press, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Springer, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Springer, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: Lucky's Textbooks, Dallas, TX, U.S.A.
Book
Condition: New.
Published by Springer, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Psychology Press, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Taylor & Francis, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: moluna, Greven, Germany
Book Print on Demand
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Geoffrey Bowker, Geoffrey Bowker, Susan Leigh Star, Les Gasser, William TurnerThis book is the first to directly address the question of how to bridge what has been termed the great divide between the approaches of systems developers and those of s.
Published by Springer Basel, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Discusses new approaches to pharmaceutical interventionIncludes new findings from stem cell researchWith numerous illustrationsEpigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potent.
Published by Springer Basel, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: moluna, Greven, Germany
Book Print on Demand
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Discusses new approaches to pharmaceutical interventionIncludes new findings from stem cell researchWith numerous illustrationsEpigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potent.
Published by Taylor and Francis, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: PBShop.store US, Wood Dale, IL, U.S.A.
Book Print on Demand
HRD. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by Springer Basel Okt 2010, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders.Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML.This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications. 280 pp. Englisch.
Published by Lawrence Erlbaum Assoc Inc, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: Revaluation Books, Exeter, United Kingdom
Book
Hardcover. Condition: Brand New. 1st edition. 496 pages. 9.50x6.50x1.50 inches. In Stock.
Published by Taylor & Francis Inc, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Book Print on Demand
Hardback. Condition: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days.
Published by Taylor and Francis, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
Book Print on Demand
HRD. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.
Published by Springer, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Book Print on Demand
Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book.
Published by Springer Basel, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders.Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML.This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications.
Published by Springer Basel, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: AHA-BUCH GmbH, Einbeck, Germany
Book
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders.Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML.This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications.
Published by Psychology Press, 1997
ISBN 10: 0805824022ISBN 13: 9780805824025
Seller: California Books, Miami, FL, U.S.A.
Book
Condition: New.
Published by Springer Basel Mrz 2012, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Book Print on Demand
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Epigenetics has emerged recently as an important area of molecular biological studies. Epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. Epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders.Recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. A few epigenetically active drugs, for example histone deacetylase inhibitors (HDACi) and DNA methyltransferase (DNMT) inhibitors, have been approved by FDA for treatment of cancers such as CTCL, MDS, and AML.This volume explores the scientific background for clinical applications of epigenetically active drugs. Included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by RNA interference (RNAi) and microRNAs, as well as new findings from stem cell research which are relevant to pharmacological applications. 280 pp. Englisch.
Published by Springer Verlag, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: Revaluation Books, Exeter, United Kingdom
Book
Paperback. Condition: Brand New. 2011 edition. 280 pages. 9.20x6.10x0.64 inches. In Stock.
Published by Springer, 2012
ISBN 10: 3034803052ISBN 13: 9783034803052
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Paperback. Condition: Like New. Like New. book.
Published by Springer, 2010
ISBN 10: 3764389885ISBN 13: 9783764389888
Seller: Mispah books, Redhill, SURRE, United Kingdom
Book
Hardcover. Condition: Like New. Like New. book.